1 study on ANGIOBONE-P1 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This study provides compelling evidence that targeting the angiogenic niche with AngioBone-P1 can effectively stimulate robust bone repair in osteoporosis, moving beyond merely slowing bone loss. The ability of this p…